US4251510A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production
Assignee: Bayer Corp
•
Filing: 1979-08-15
•
Granted: 1981-02-17
•
Expires: 1999-08-15
Abstract
Abstract Plasma Protein Fraction substantially free of bradykinin, kininogen and prekallikrein activators is obtained by treating Cohn Supernatant II plus III at about neutrality with a siliceous substance for a period of time sufficient to bring about essentially complete conversion of intrinsic kininogen into bradykinin. Subsequently, after being separated from Cohn Fraction IV-1, the Plasma Protein Fraction is reconstituted and held for a period of time sufficient to allow substantially complete destruction of bradykinin by kininase. Methods are disclosed for the destruction of prekallikrein activators which may be present in Plasma Protein Fraction.
Inventors
- 👤 Donald L. Tankersley
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 06:56
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/76; C07K14/765; C07K14/46; C07K14/47; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/829; Y10S530/83; Y10S530/831
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
121 words
A sterile aqueous solution of heat-stable Plasma Protein Fraction (Human) suitable for injection, wherein about 5 grams of Plasma Protein Fraction (Human) per 100 milliliters of sterile aqueous solution contains no greater than about 16 milli-units per milliliter Factor XIIa and fragments thereof capable of activating prekallikrein, no greater than about 10 nanograms bradykinin equivalents per milliliter of kininogen, and less than about 10 nanograms per milliliter of bradykinin, said Plasma Protein Fraction (Human) being a mixture of constituent plasma protein isolated from human plasma by a modified Cohn fractionation process and containing at least 83% albumin and no more than 17% alpha and beta globulins having molecular weights similar to that of albumin and no more than 1% gamma globulin.
Claim 2
Dependent Claim
121 words
A sterile aqueous solution of heat-stable Plasma Protein Fraction (Human) suitable for injection, wherein about 5 grams of Plasma Protein Fraction (Human) per 100 milliliters of sterile aqueous solution contains no greater than about 16 milli-units per milliliter Factor XIIa and fragments thereof capable of activating prekallikrein, no greater than about 10 nanograms bradykinin equivalents per milliliter of kininogen, and less than about 10 nanograms per milliliter of bradykinin, said Plasma Protein Fraction (Human) being a mixture of constituent plasma protein isolated from human plasma by a modified Cohn fractionation process and containing at least 83% albumin and no more than 17% alpha and beta globulins having molecular weights similar to that of albumin and no more than 1% gamma globulin.
Claim 3
Dependent Claim
13 words
The solution of claim 1 wherein the protein concentration is about 5 percent.
Claim 4
Dependent Claim
20 words
The solution of claim 1 which includes a stabilizer selected from the group consisting of sodium acetyltryptophan and sodium caprylate.
References Cited (Backward Citations)
US2958628A
Cited
US3100737A
Cited
US3686395A
Cited
US3876775A
Cited
US4000121A
Cited
US4017470A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1984-02-17 | 1984-08-18 | 1985-02-17 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1988-02-17 | 1988-08-18 | 1989-02-17 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1992-02-17 | 1992-08-18 | 1993-02-17 | $7700.00 | Window Closed / Lapsed |